Boothbay Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
447,019
+185,798
| +71% | +$6.18M | 0.29% | 35 |
|
|
2025
Q1 | $7.65M | Buy |
261,221
+9,447
| +4% | +$277K | 0.2% | 98 |
|
|
2024
Q4 | $8.27M | Buy |
251,774
+18,718
| +8% | +$615K | 0.2% | 116 |
|
|
2024
Q3 | $10.4M | Buy |
233,056
+9,077
| +4% | +$403K | 0.24% | 68 |
|
|
2024
Q2 | $9.66M | Sell |
223,979
-45,000
| -17% | -$1.94M | 0.23% | 63 |
|
|
2024
Q1 | $7.86M | Sell |
268,979
-17,466
| -6% | -$511K | 0.15% | 92 |
|
|
2023
Q4 | $6.38M | Buy |
+286,445
| New | +$6.38M | 0.16% | 110 |
|
|
2022
Q3 | – | Sell |
-539,006
| Closed | -$12M | – | 1916 |
|
|
2022
Q2 | $12M | Buy |
539,006
+432,672
| +407% | +$9.59M | 0.31% | 25 |
|
|
2022
Q1 | $3.1M | Buy |
+106,334
| New | +$3.1M | 0.07% | 321 |
|
|
2021
Q3 | – | Sell |
-9,517
| Closed | -$524K | – | 1621 |
|
|
2021
Q2 | $524K | Sell |
9,517
-2,241
| -19% | -$123K | 0.02% | 853 |
|
|
2021
Q1 | $607K | Buy |
+11,758
| New | +$607K | 0.02% | 682 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1049 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 731 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 730 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 658 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 617 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 637 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 461 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 249 |
|